Home Cart Sign in  
Chemical Structure| 95635-56-6 Chemical Structure| 95635-56-6

Structure of Ranolazine 2HCl
CAS No.: 95635-56-6

Chemical Structure| 95635-56-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Ranolazine 2HCl is a calcium uptake inhibitor via the sodium/calcium channal, used to treat chronic angina.

Synonyms: CVT 303 dihydrochloride; RS 43285; Ranolazine(hydrochloride)

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Ranolazine 2HCl

CAS No. :95635-56-6
Formula : C24H35Cl2N3O4
M.W : 500.46
SMILES Code : O=C(NC1=C(C)C=CC=C1C)CN2CCN(CC(O)COC3=CC=CC=C3OC)CC2.[H]Cl.[H]Cl
Synonyms :
CVT 303 dihydrochloride; RS 43285; Ranolazine(hydrochloride)
MDL No. :MFCD03788770
InChI Key :RJNSNFZXAZXOFX-UHFFFAOYSA-N
Pubchem ID :71279

Safety of Ranolazine 2HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H317-H319
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • Calcium Channel

In Vitro:

Cell Line
Concentration Treated Time Description References
HEK293T cells 10 µmol/L To evaluate the effect of ACBI1 on SMARCA4 protein levels in HEK293T cells, results showed that ACBI1 treatment led to a reduction in SMARCA4 protein levels. PMC8154177
Mouse cardiomyocytes 10 µmol/L Empagliflozin significantly reduced late-INa and total sodium current in cardiomyocytes from heart failure mice, restoring them to levels similar to those in sham-operated controls. PMC8154177
HEK cells (expressing NaV1.5) 50 μM 10 minutes Ranolazine reduced peak Na+ current by 37±5% and inhibited the mechanosensitivity of NaV1.5 induced by bath flow. PMC3392778
Murine ventricular cardiac myocytes 50 μM 10 minutes Ranolazine inhibited the flow-induced increase in peak Na+ current, reducing peak Na+ current by 68±3%. PMC3392778
WM9 cells 50 µM or 100 µM once per week Inhibited fatty acid oxidation and reduced the formation of resistant cells PMC10513932
A375 cells 100 µM once per week PLX51107 combined with BRAFi/MEKi significantly inhibited the growth of A375 cells and reduced S-phase entry. PMC10513932
MDA-MB-231-Luc cells 50 μM 24 hours To evaluate the effect of IKBKE knockdown on cell migration and invasion capabilities, results showed that IKBKE knockdown significantly reduced cell migration and invasion. PMC4295566
Detergent extracted fiber bundles 10 μmol/L 15 minutes To assess the effect of Ranolazine on myofilament response to Ca2+ in DOCA-salt hearts. Results showed that Ranolazine reduced maximum tension and Ca2+ sensitivity, restoring them to levels similar to sham fibers. PMC3314887
Cardiomyocytes 10 μmol/L 10 minutes To evaluate the effect of CORM-3 on mitochondrial membrane potential, results showed that CORM-3 pretreatment attenuated PAO-induced MPT PMC3314887
MDA-MB-231-Luc cells 50 μM 24 hours To evaluate the effect of IKBKE knockdown on cell migration and invasion capabilities, results showed that IKBKE knockdown significantly reduced cell migration and invasion. PMC4295566

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice A375 human melanoma xenograft model 50 mg/kg intraperitoneal injection Once daily for up to 50 days To assess the effect of Ranolazine on BRAF inhibitor therapy, results showed that Ranolazine significantly reduced tumor growth and delayed the onset of resistance PMC10513932
NMRI nude mice Immunodepressed mice model 50 mg/kg/day Intraperitoneal injection 5 days per week for 8 weeks Significantly reduced lung colonization by Na V1.5-expressing human breast cancer cells PMC4295566
Mice Scn5a S571E and S571A knock-in mouse models 1 µM Single dose Ranolazine normalized isoproterenol-induced repolarization defects PMC4543581
Mice DOCA-salt hypertensive mouse model 5 mg/kg intravenous injection followed by infusion at 4.8 mg/kg/h intravenous injection Single injection followed by continuous infusion To evaluate the effect of Ranolazine on diastolic function in DOCA-salt mice. Results showed that Ranolazine significantly improved diastolic function, restoring the EDPVR slope to control levels without affecting systolic function. PMC3314887

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.00mL

0.40mL

0.20mL

9.99mL

2.00mL

1.00mL

19.98mL

4.00mL

2.00mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories